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Urodynamics are the gold standard in the diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement but the clinical value of uro dynamic investiga tion in daily practice has been criticized. 1 In the past there has not been a great effort to improve the clinical method of diagnosis of bladder outlet obstruction in elderly men, prob ably because of the acceptable success rate of therapy (gen erally transurethral resection of the prostate). However, the number of alternative treatments currently available is rap idly increasing but they do not seem to have high success rates. On the other hand, the threshold for seeking medical care for lower urinary tract symptoms seems to have de creased, possibly because of the availability of these alterna tives. To take advantage of less invasive therapies selection criteria are needed. Improving clinical diagnosis may become useful for stratification of patients.
Urodynatnics remain invasive, time-consuming and costly, and will not be implemented in daily routine practice for establishing the diagnosis in every elderly man with lower urinary tract symptoms. The value of urodynamics in pre dicting the outcome of surgery is limited, This conclusion is based on reports th at patients without uro dynamically con fined bladder outlet obstruction are symptomatically the same after transurethral resection of the prostate compared to those with obstruction when all patients underwent sur gery, [2] [3] [4] However, we performed urodynamics routinely to assess all patients with benign pro static enlargement for more than 2 years. The results of urodynamics were used to select patients who did not immediately require surgery for bladder outlet obstruction. In addition to complete urodynamics rec tal ultrasound of the prostate and at least 1 spontaneous free uroflowmetry were done in all patients. Serum prostate spe cific antigen was measured and prostate biopsies were ob tained when necessary. Furthermore, patients were asked to complete an International Prostate Symptom Score (I-PSS) and a Madsen symptom score questionnaire. We report the results of urodynamics in a large, referred but random group Accepted for publication October 13, 1995. of patients with benign pro static enlargement and lower urinary tract symptoms, The outcome of urodynamics was compared to the 2 symptom scores, and the free uroflowmetry results, post-void residual level and prostate size meas urem ent by transrectal ultrasound. Based on these compar isons a clinical score was developed, which may prove valu able to predict the probable presence of bladder outlet obstruction.
MATERIAL AND METHODS
We performed urodynamics in 871 consecutive men with benign prostatic enlargem ent and/or lower urinary tract symptoms in this retrospective study to analyze the grade of bladder outlet obstruction. Of the original 904 patients 33 were excluded from study due to age younger than 50 years.5 However, 16 of the excluded patients (46.9%, mean age 46.7 years, range 41 to 49) had obstruction and the largest pros tate was 95 cm.3 (mean 30.2). All patients were referred to our clinic because of prostatism. In 23 patients (2.6%) not excluded from analysis the prostate was between 17 and 20 cm.3. A few patients (1 to 2%) able to perform free urine flow were unable to void during urodynamics due to inhibition and were excluded from analysis.
All patients were considered neurologically normal based on history, symptoms and physical examination (no motor, sensory or reflex deficits). Urine sediment and culture were ;ative at the time of urodynamics. Patients in acute reten tion were not included since retention is an almost absolute indication for surgery. However, patients with probably chronic large amounts of residual urine were included in the study when they were able to void during urodynamics.
A Dutch translation of the Madsen symptom score ques tionnaire was used, which has been available in The Neth erlands since its publication in English. It has been success fully used in many international multicenter studies. The International Consensus Committee of the World Health Or ganization (WHO) international consultation on benign pros tatic hyperplasia recommended translations of the I-PSS questionnaire.5 The Flemish/Dutch translation is similar to the Dutch translation, which we have used since publication of the original American Urological Association-7 symptom score questionnaire.
To evaluate the structure of the prostate and prostate volume transrectal ultrasound was performed using a Combison 330 scanner with a 7.5 MHz. transducer for transrectal scanning (Multiplane 3-D VRW 77AK). The planimetric method was used to calculate prostate volume. Free uroflowmetry was done privately when the patient presented with a normal to severe urge to void. Flow was measured using a Urodyn 1000* flowmeter, Urodynamics were performed with an 8F transurethral lumen catheter with an intravesical micro-tip pressure sen sor. Before cystometry the bladder was emptied through the lumen of the transurethral catheter to quantify residual vol ume after free uroflowmetry. Abdominal pressure was re corded intrarectally with an 8F micro-tip sensor catheter. Pressure sensors were set at zero equals atmospheric pres sure before placement. The bladder was filled with water at 20C at a filling speed of 50 ml. per minute with the patient supine. Filling was stopped when the patient expressed a strong urge to void, and voiding in the standing position was allowed privately.
Digitally stored urodynamic data were analyzed with a urodynamic analysis computer program developed at our department. To quantify bladder outlet obstruction pressureflow graphs were fitted with a passive urethral resistance relation curve at the lowest pressure part of the graph. Min imal pressure during voiding and theoretical cross-sectional urethral lumen were derived using the passive urethral re sistance relation curve.6 Calculation of urethral resistance factor was based on the point of maximum flow (Qmax) and corresponding detrusor pressure.7 Correction for artifacts was done as necessary. U rethral resistance factor of 29 cm. water or greater indicated bladder outlet obstruction.8 The linear passive urethral resistance relation pressure-flow no mogram was used as a clinical classes scale: classes 0 and 1-no bladder outlet obstruction, 2 and 3-moderate obstruc tion and greater than 3-severe obstruction.
Statistical significance of the differences between mean values was tested with a paired samples t test when appro priate or a nonparametric Wilcoxon matched pairs signed ranks test as necessary. Differences between multiple group means were tested with Kruskal-Wallis 1-way analysis of variance. Pearson's coefficient of correlation was used for correlation analysis. Logistic regression analysis was per formed to facilitate the development of a clinical score. A commercially available computer software package was used for statistical analysis. Table 1 shows the average results of symptom scores, free * Dantec Medical, Inc., Campbell, California. uroflowmetry and ultrasound prostate volume determina tion. A self-administered I-PSS questionnaire was completed by 707 patients and a Madsen symptom score questionnaire was completed by 693. A free flow rate was recorded imme diately before urodynamics in 815 patients and evaluable residual urine data after this voiding were obtained for 807. All urine flow values were included when voided volume was greater than 50 ml. Data on prostate size were evaluable for 813 patients.
RESULTS
The results of urodynamics for the group are also shown in table 1. Mean maximal flow during urodynamics (7.3 ml. per second) was significantly less than the mean free maximal flow (10.7 ml. per second, t test, p = 0.0001). The mean of the individual differences (free Qmax -urodynamic Qmax) was 3.44 ml. per second (range of differences -33 to 20, standard deviation 4.63). In 62.6% of the cases the individual differ ence was less than 4 ml. per second. Eight patients with extreme differences (-3 3 to -7 ml. per second) due to unrep resentative voiding during urodynamics were excluded from further analysis at this point. Five patients with a much better flow during urodynamics (differences of greater than 14 ml. per second) were included in the study. Although linear passive urethral resistance relation estimation of blad der outlet obstruction was done in another 31 patients, ure thral resistance factor analysis was too unreliable for our study because the catheter slipped out during voiding or the uroflowmeter was disturbed. Therefore, these patients were excluded from urethral resistance factor analysis but in cluded in linear passive urethral resistance relation analysis. Complete urodynamic data on bladder outlet obstruction were available in 821 cases.
There was no selective exclusion because of artifacts al though patients who clearly had no obstruction tended to have larger differences in urodynamic flow rate, as we re ported earlier.10 Based on linear passive urethral resistance relation class 224 patients (28.2%) had no bladder outlet obstruction and based on urethral resistance factor analysis 304 (38.5%) had no obstruction (table 2) . Six patients had obstruction on urethral resistance factor analysis but not according to linear passive urethral resistance relation class, and 85 (9.9%) had moderate obstruction according to linear passive urethral resistance relation class and obstruction on urethral resistance factor analysis. Two patients had no ob struction on urethral resistance factor analysis and severe obstruction according to linear passive urethral resistance relation class. We observed a significant difference between free and urodynamic maximal flows. Although 119 patients (15.8%) had improved maximal flow during urodynamics, in 632 (84.2%) maximal flow of pressure-flow voiding was less. We regard this difference (less than 4 ml. per second in 63% of cases) as systematic due to the transurethral catheter and the circumstances of the investigation. Since bladder outlet obstruction is quantified by the pressure-to-flow ratio, pas sive urethral resistance relation and linear passive urethral resistance relation analyses are not sensitive to maximal flow differences. Furthermore, pressure-flow analysis is cal ibrated for transurethral investigation.
Clinical parameters categorized according to urodynamic results are compared in tables 3 and 4. All parameters showed significant differences between the groups. However, the magnitude of the differences in symptoms between pa tients with and without bladder outlet obstruction was less than the differences on uroflowmetry or in prostate size. Analysis showed good correlation between both symptom scores and good correlation of the symptom scores with I-PSS quality of life (table 5).5 There was no difference in I-PSS quality of life score between patients with and without obstruction (mean score overall 3.83, with obstruction 3.87 and without obstruction 3.75), Urodynamic correlations with clinical prostate score are shown in table 6. Figure 1 shows age and prostate size of all patients. There was a significant correlation of age with prostate size (r = 0.2946, p -0.001). Table 7 shows average prostate size of distinct age groups in our study.
From the data in tables 3 and 4 we concluded th at the existence of bladder outlet obstruction in these patients cor related with free uroflowmetry and prostate size at a high level compared to the number of symptoms. This conclusion does not imply that we consider measurement of symptoms or derivation of a reliable symptom score of lesser clinical importance. On the contrary, symptoms are the most fre quent reason for the patient to seek medical care, The level of symptoms and their bothersomeness for the patient are im portant indicators of the need for medical intervention and important means to evaluate the success of intervention. However, we found poor correlation between grade of bladder outlet obstruction and level of symptoms. Therefore, we con clude that the decision to treat can be based on symptoms and/or bothersomeness of symptoms but, especially if differ-ent types of therapy are available, the treatm ent choice will be guided by the result of objective investigation(s). Since determ ination of prostate size and uroflowmetry with the quantification of post-void residual urine are simple m eas urem ents with low morbidity, we found it worthwhile to derive a scoring system for these clinical investigations, which could be used to predict the presence of bladder outlet obstruction in an elderly m an w ith prostatic enlargement and lower urinary tract symptoms.
Development of the clinical prostate score. Table 6 shows th a t of the param eters maximal flow is the most im portant predictor of bladder outlet obstruction because it correlates well with urodynamic param eters. The correlation coeffi cients of prostate size, voided volume and post-void residual follow respectively. Logistic regression analysis with these 4 param eters versus obstruction or no obstruction confirmed th a t maximal flow was the best predictor for the presence of obstruction, The relative power or weight assigned to each param eter to predict bladder outlet obstruction was esti mated on the basis of this logistic regression. Therefore, logistic regression analysis was not an end point of analysis. The analysis was merely used as a tool to construct the clinical score. The 4 param eters entered in regression anal ysis showed only poor individual statistical correlation (best correlation maximal flow with voided volume, r2 = 0,478) and, therefore, logistic regression on these param eters was not confounded. The weight of the param eters derived from this analysis was used to assign points to the results of the various param eter values. The cutoff points of the classes were based on analysis of the histograms of the various param eters as well as on analysis of scatterplots of the pa ram eters in relation to the quantifiers of bladder outlet ob struction. Table 8 shows the param eters and the scoring points th a t we assigned to each param eter. Clinical prostate score, th a t is the total of the points achieved, was determined for 770 patients and compared to the urodynamic diagnosis of bladder outlet obstruction in 705. The possible range was 0 to 27 points and the average clinical prostate score was 10.4 (standard deviation 5,8) in this group.
There was a significant difference in clinical prostate score of patients with and without bladder outlet obstruction (mean 7,3 points for the 271 patients without and mean of 12.3 for the 434 with obstruction, t test, p <0.0001). In figure 2 a urethral resistance factor of greater than 28 indicates obstruction. Referring to linear passive urethral resistance relation, m ean values for no obstruction (7,5 points), moder ate obstruction (9.6) and severe obstruction (13,7) showed statistically significant differences (Kruskal-Wallis test, p <0.00001). Of the group 344 patients (48.8%) had a clinical prostate score of greater than 11 points of whom 247 (80,7%) had bladder outlet obstruction on urodynamics. Of the 250 patients (35.5%) w ith a clinical prostate score of less than 8 points 64% had no obstruction. Of the 55 patients with an I-PSS of 0 to 7 (mildly symptomatic) 26 (51%), of the 382 with an I-PSS of 8 to 19 (moderately symptomatic) 224 (61%) and of the 270 w ith an I-PSS of 20 or greater (severely symptom atic) 158 (63%) had obstruction. 
DISCUSSION
In a large group of men with benign pro static enlargement and symptoms of lower urinary tract dysfunction we confirm a poor correlation between urodynamic findings and symp toms.11-13 The correlation of the results of urodynamics with prostate size, as determined by transrectal ultrasound or free uroflowmetry, was better.14, 15 The correlation of isolated ob jective parameters is generally believed to be too inaccurate for clinical decision making. However, we combined the re sults of these noninvasive investigations to derive a clinical scoring system, This score correlated well with the results of urodynamics. We excluded a limited number of patients from these analyses to prevent a retrospective observation bias, The procedures for prostate size estimation and uroflowmetry are routine, and results were not manipulated. Since the core of the diagnosis was urodynamics, some of these results have been excluded, as stated previously. Therefore, we have also included 1 urine flow value recorded just before urodynamics. Because there is a possibility that urine flow could improve on another occasion and almost 16% of the patients had better urine flow during urodynamics, we in cluded these data. Furthermore, since urine flow can only improve with more attempts (a worse result shall not be used for analysis) the positive predictive value of the score will also only improve. However, prospective use of the score is needed to evaluate the validity of the scoring points.
It is important to emphasize that this score will never perfectly predict the presence or confirm the absence of blad der outlet obstruction, The sensitivity of clinical prostate score to detect obstruction when the lower score limit is 11 points is high in this group of patients (80.7%) but specificity is less (53.1%). Lowering the limit increases specificity, and only 11.8% of the patients with a clinical prostate score of less than 8 had severe bladder outlet obstruction on urodynamics.
The correlation between clinical prostate score and the results of urodynamics is superior to that between urody namic bladder outlet obstruction and symptoms or symptom scores. For example, of the patients with mild or moderate symptoms 57.2% had obstruction. Also, the combination of clinical parameters in clinical prostate score results in a superior correlation with urodynamic results compared to the results of the separate clinical parameters, as shown by the coefficients of correlation of these parameters with the available obstruction parameters (table 6) .
In general, clinical prostate score provides reassurance for clinicians since it refers to clinical experience. The older patient wiui a large prostate, small voided volume, low m ax imal flow and large post-void residual is the ideal candidate for the removal of obstruction. In our opinion this score and its good correlation with bladder outlet obstruction are m ath ematical evidence of this clinical experience. However, tre a t ing patients can never depend on the calculation of a score, and clinical prostate score must be interpreted as an indica tion of the relative value of each param eter or investigation in establishing the likelihood of obstruction without perform ing complete invasive urodynamics.
Others have studied symptoms and prostate size in a screened population.16*17 Men were excluded from study when they had already been treated by a urologist and/or when they had a history of prostatic surgery. The prostates of the patients in our study were plus or minus 5 to 10 cm.3 larger on average compared to those of the group th a t was screened, indicating th at the exclusion of treated pa tients in the screening study may have caused bias toward smaller prostate size. Mean I-PSS of the reported screening group was 6.2 points and 30% had moderate or severe symp toms. Mean I-PSS quality of life score was 1.4, and there was a high correlation between I-PSS and quality of life. The correlation between I-PSS and uroflowmetry parameters was low. 16 The pattern of these correlations is comparable to our results, although prostate sizes, mean total I-PSS and both ersomeness (I-PSS quality of life score) were lower in the screening study. We conclude that our clinical patients dif fered significantly on average from the screened men only in the level of symptoms and less in objective parameters. The high correlation of I-PSS quality of life score and total I-PSS in both studies indicates that symptoms are predominantly influenced by bothersome ness and to a lesser extent by blad der outlet obstruction. 18 WHO proposed recommendations concerning the diagnos tic evaluation of patients presenting with symptoms suggest ing prostatism. Uroflowmetry and measurement of residual urine are recommended diagnostic tests, while the assess ment of prostatic size and shape is regarded as optional.6 However, alternative treatments are not included in the WHO decision tree and reference values are not provided. The outcome of surgical treatm ent in relation to diagnostic investigations has been the subject of other studies.4*19'20 Flow rate has been shown to predict outcome. The outcome was less favorable in patients with a preoperative maximal flow of 15 ml. per second or greater. Uroflowmetry is recom mended for the evaluation of prostatism,21 and we confirm an acceptable correlation of uroflowmetry with bladder outlet obstruction. Combining the results of uroflowmetry with those of other diagnostic tests, as shown in our study, im proves diagnostic accuracy. We are convinced that the use of objective testing in referred patients with benign prostatic enlargement and lower urinary tract symptoms will augment the justification of treatment, and th a t clinical prostate score will be helpful in the selection of candidates for surgery or alternative therapies. Clinical prostate score can be used to select patients for surgical treatm ent when urodynamics are not available but it can also be used to select patients for urodynamics.
A recent study shows that patients with moderate bother someness of symptoms do better after transurethral resec tion of the prostate compared to watchful waiting. 22 Although reoperation for stricture was performed in 9.3% of the pa tients within 3 years of foliowup and 8.2% of the transure thral resection of the prostate procedures were regarded as unsuccessful, patients in the watchful waiting group had more retention and more infections. An increasingly large amount of residual urine was regarded as an indication for crossover to surgery in 8.7% of the cases, while 30 to 40% of those in the watchful waiting group had symptomatic im-provement. Hypothetically these men could represent the 40% of patients without bladder outlet obstruction in our group w ith moderate symptoms. However, the symptomatic effect of watchful waiting in patients stratified according to urodynamic grade of bladder outlet obstruction is not yet established, although watchful waiting, when partially indi cated by the results of urodynamics, can be a serious alter native. 23 The findings of Wasson et al22 may confirm our results th a t solitary assessm ent of symptoms is ineffective for selecting candidates for alternatives to surgery. There fore, we find it confusing th a t O ester ling, in debating the alternatives to treatm ent, referred to the study of Wasson et ai and recommended selection of treatm ent based on symp toms, stating th a t there exist only relative indications to treat and th at "the patient m ust be consulted."24 c o n c l u s i o n s Prostate size and the results of free uroflowmetry meas urem ent provide useful nonurodynamic indicators for the presence of bladder outlet obstruction. We used a combina tion of these investigations to derive a urodynamically vali dated, noninvasive, disease specific clinical prostate score. In comparison with analysis of symptoms or separate analysis of clinical evaluations, this clinical prostate score better pre dicts the presence of bladder outlet obstruction.
